Search results

{{r|Monoclonal antibody}}

{{r|Monoclonal antibody}}

* [[Cetuximab]] (IMC-C225) is a recombinant, human/mouse chimeric [[monoclonal antibody]] that binds to [[epidermal growth factor receptor]] (ErbB1, EGFR) and may * [[Catumaxomab]]. Is a monoclonal antibody against CD3 ([http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein&term=NM_0

{{r|Monoclonal antibody}}

[[Antitoxin]]s, drugs using [[monoclonal antibody|monoclonal antibodies]], etc., which directly attack or neutralize the path ...directly counteract the effects of the pathogen, as do [[antitoxin]]s or [[monoclonal antibody|monoclonal antibodies]] that kill organisms, passively add immune defensive

}}</ref> [[monoclonal antibody]] consisting of humanized [[murine]] antibody with antigen-binding, complem

The leading edge of approved treatment, however, are specific [[monoclonal antibody|monoclonal antibodies]].

[[Trastuzumab]] is a [[monoclonal antibody]] against the ErbB-2 receptor that lengthens remission time in metastatic [

* [[Infliximab]] (Remicade) (pronounced in flix' i mab) is a chimeric monoclonal antibody that blocks the action of TNF-alpha by binding to it.<ref>{{CZMed|Inflixima

* [[Adalimumab]] is a [[monoclonal antibody]].

...opurine]] and [[azathioprine]], as well as [[methotrexate]]. Recently, a [[monoclonal antibody]] against [[tumor necrosis factor-alpha]], [[infliximab]], has come into us

[[Rituximab]], a [[monoclonal antibody]], was found to be safe by a [[systematic review]] of 21 studies, although

...s of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]] [[abciximab]] and the small-molecule agents [[tirofiban]] and [[eptifiba

...he person's blood. Any p24 protein in the person's blood will stick to the monoclonal antibody and enzyme-linked antibody to the monoclonal antibodies to p24 causes a col

...d for [[non-Hodgkin’s lymphom]]a. ⁹⁰Y-Ibritumomab Tiuxetan, a [[monoclonal antibody]], is currently unavailable in generic form due to its patented brand name, ...ation with radioactive ⁹⁰[[Yttrium]]. Ibritumomab Tiuxetan, the monoclonal antibody, is therefore coupled with a radioactively [[cytotoxic]] agent capable of d

...rpr|molecular genetics}} {{rpr|molecular phylogeny}} {{rpr|mollusc}} {{rpr|monoclonal antibody}} {{rpr|morphogenesis}} {{rpr|morphometrics}} {{rpr|morula}} {{rpr|MRI}} {{

...e development and control of the [[immune system]] and the production of [[monoclonal antibody|monoclonal antibodies]]

...rpl|molecular genetics}} {{rpl|molecular phylogeny}} {{rpl|mollusc}} {{rpl|monoclonal antibody}} {{rpl|morphogenesis}} {{rpl|morphometrics}} {{rpl|morula}} {{rpl|MRI}} {{

*[[Monoclonal antibody/Definition]]

...ion]] - [[molecular genetics]] - [[molecular phylogeny]] - [[mollusc]] - [[monoclonal antibody]] - [[morphogenesis]] - [[morphometrics]] - [[morula]] - [[MRI]] - [[Muller

...fit for some patients but generally do not slow disease progression. Newer monoclonal antibody treatments against beta-amyloid protein, for example, the drug Leqembi, hav

...ontrolled trial]], the [[relative risk ratio]] of adjunct treatment with [[monoclonal antibody|monoclonal antibodies]] against C. difficile toxins, as compared to [[place

...ions measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus ''J Clin Endocrin

The [[monoclonal antibody]] against [[interleukin]]-1 beta, [[canakinumab]], may help according to a

...ng allows plants to be modified to express proteins such as a therapeutic monoclonal antibody used in the treatment of arthritis, vaccine proteins, or for treatment of d

Cetuximab, an I_gG1 chimeric monoclonal antibody against epidermal growth factor receptor, may help according to a [[randomi

...refractory cases. TNF-a is a cachexin or cachectin. Its inhibitors, all [[monoclonal antibody|monoclonal antibodies]]; they are immunosuppressive with attendant risks. T

...m, and cerebellum regions. Using an immunohistochemical analysis for OX-42 monoclonal antibody, they found a marked reduction of microglial activation in ribavirin-treate

...e patients may be candidates for the drug [[trastuzumab]] (Herceptin), a [[monoclonal antibody]] that targets this protein. [[Trastuzumab]] may be used both in the posts ...presses an over-abundance of the [[erbB-2 receptor]] (HER2, HER2/neu), a [[monoclonal antibody]] known as [[trastuzumab]] (Herceptin ®) is used to block the activity of

Denosumab is a humanized monoclonal antibody that inhibits osteoclasts.<ref name="pmid16495394">{{cite journal |author=M

...tural substances, or might, as soon as some folate antagonist or TNF-alpha monoclonal antibody becomes available, do provings on it and add it to their lists of remedies?

...action of either an individualized genetic treatment using a customized [[monoclonal antibody]], or accept the hypotheses of potentiation of water, I will not accept the

...he experimental group may have received a different, personalized modified monoclonal antibody. If there are better outcomes in the experimental group, the trial confirms ...that there was commercial justification to develop a specific neutralizing monoclonal antibody.

...t first to look for the genetic pattern, and, perhaps try, ''in vitro'', a monoclonal antibody or other agent tailored for the individual problem. Only if the circulating